- Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence GenerationSAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular Medical, Inc, ("Modular Medical" or "the Company") NASDAQ:MODD, a commercial-stage medical device com…
SAN DIEGO, CA AND ROSEMONT, IL / ACCESS Newswire / July 16, 2026 / Modular Medical, Inc., ("Modular Medical" or "the Company") NASDAQ:MODD, a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, today announced an important p…
Submission Covers Software Enhancements for Patient Flexibility and Customization of PivotSAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") NASDAQ:MODD, a leader in innovative, patient-centric insulin delivery technology, today announced sub…
First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial CompanyPivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent Adults Still Relying on Multiple Daily Injections, a Multibillion-Dollar MarketSAN DI…
Modular Medical, Inc. reported a net loss of $28.2M for fiscal 2026 versus a net loss of $18.8M in fiscal 2025, with basic and diluted net loss per share of $(12.36) in 2026 compared with $(15.26) in 2025.Financial HighlightsBusiness HighlightsOriginal SEC Filing: Modular Medical, Inc. [ MODD ] - 1…
